NCT04994275

Brief Summary

Iron deficiency is a common state during the perioperative period. Data from literature do not allow us to conclude on how perioperative iron deficiency influences postoperative infections occurrence. This prospective observational study aims to assessed the postoperative infections incidence according to the preoperative iron-stock status.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
413

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 6, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

November 3, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2023

Completed
Last Updated

October 3, 2022

Status Verified

September 1, 2022

Enrollment Period

9 months

First QC Date

July 29, 2021

Last Update Submit

September 29, 2022

Conditions

Keywords

iron-deficiencyinfectionpostoperativemajor surgery

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative infectious complication

    The main goal of this study is to compare the incidence of postoperative infectious complications according to the preoperative patient's iron-stock status (supplemented or not). The primary outcome is the occurrence of at least one infection complication within 90 days after surgery. The various infections recorded are defined by the Center for disease control and prevention and included: * superficial surgical site infection (within 30 days after surgery) or deep surgical site infection (within 30 days after surgery or 90 days if an implant is in place) * pneumonia * urinary infection * bacteriemia * catheter infection

    90 days

Secondary Outcomes (3)

  • To assess the prevalence of preoperative iron deficiency according to the surgical field

    Preoperative

  • To assess the incidence of postoperative infections according to the type of surgery

    90 days

  • To assess the incidence of overall postoperative complications according to the iron-stock status

    90 days

Study Arms (1)

Patients admitted to undergo a major elective surgery

Other: no intervention, but presence of ID or not

Interventions

This is an observational study regarding patients admitted to undergo a major elective surgery supposed to last more than an hour. Investigators will analyzed the incidence of postoperative infections up to 90 days after surgery according to the preoperative iron status: iron deficiency (defined as a ferritin of less than 100 µg/L or \<300 µg/L And TSAT\<20%) or no iron deficiency

Patients admitted to undergo a major elective surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult admitted to undergo elective surgery supposed to last more than an hour and who had an iron-deficiency assessment realized by blood sample as part of standard care

You may qualify if:

  • Adult (≥ 18 years old)
  • Iron-deficiency assessment realized by blood sample as part of standard care
  • Elective surgery supposed to last more than an hour

You may not qualify if:

  • Adult under tutelage
  • Emergency surgery
  • Refusal of data collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Angers

Angers, France

Location

MeSH Terms

Conditions

Anemia, Iron-DeficiencyPostoperative ComplicationsInfections

Interventions

Nuclear Receptor Subfamily 4, Group A, Member 2

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Orphan Nuclear ReceptorsDNA-Binding ProteinsProteinsAmino Acids, Peptides, and ProteinsReceptors, Cytoplasmic and Nuclear

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2021

First Posted

August 6, 2021

Study Start

November 3, 2021

Primary Completion

August 12, 2022

Study Completion

January 15, 2023

Last Updated

October 3, 2022

Record last verified: 2022-09

Locations